Clinical trial
Teriparatide for the Treatment of Idiopathic Osteoporosis in Premenopausal Women
NCT00697463 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Teriparatide for the Treatment of Idiopathic Osteoporosis in Premenopausal Women
- Lead sponsor
- Columbia University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 20, 2008
- Completion date
- January 3, 2012
- Enrollment
- 22 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
fracture, menopause, osteoporosis